Streetbeat News

Products Services

TMGEF

Thermal Energy International Inc. will present at the Virtual Investor Summit on November 21, 2024. The company, known for its energy efficiency and carbon emission reduction solutions, will also be available for 1-on-1 meetings.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

AVXL

SAVA

The article discusses the effectiveness of Panax ginseng, Anavex's Blarcamesine, and Cassava Sciences' Simufilam in treating Alzheimer's disease. Panax ginseng shows the highest effectiveness, while Anavex's Blarcamesine may slow progression in mild cases. Cassava Sciences' Simufilam shows limited effectiveness.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

WES

Western Midstream Partners, LP (NYSE: WES) announced a post-earnings interview with its CEO and CFO, providing insights into its third-quarter results. The company will also participate in several investor conferences in late 2024 and early 2025.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

MURA

Mural Oncology plc (Nasdaq: MURA) will participate in two upcoming investor conferences, highlighting its focus on developing novel cytokine therapies for cancer treatment.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

FCLIF

Full Circle Lithium Corp. (FCL) has reported over $300,000 in sales of its FCL-X™ lithium-ion battery firefighting agent in recent weeks. The company is also selling non-core equipment for $1.5 million to support manufacturing, marketing, and sales efforts.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

SBLRF

Sable Resources Ltd. has announced positive surface results and the start of a VTEM survey at its Copper Queen Project in British Columbia.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

GTGDF

Awalé Resources has reported a significant gold discovery at the Charger Zone of the Odienné Project, with a highlight of 14.7 g/t gold over 59 meters. This includes a notable section of 22.4 g/t gold over 21 meters in hole OEDD-100.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

ALK B

SPRY

ARS Pharmaceuticals has entered into an exclusive agreement with ALK to commercialize its needle-free epinephrine nasal spray, neffy®, outside the U.S. ARS will receive up to $465 million and double-digit royalties, while retaining U.S. rights.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

UNCY

Unicycive Therapeutics announced that the FDA has accepted their NDA for Oxylanthanum Carbonate, a treatment for hyperphosphatemia in dialysis patients, with a PDUFA date set for June 28, 2025. The company is preparing for a commercial launch in 2025.

Portfolio Pulse from

November 11, 2024 | 12:15 pm

DNOPY

Dino Polska is expanding rapidly in eastern Poland, focusing on smaller areas with high growth potential. Strategic investments in Agro-Rydzyna and Krot Invest aim to streamline supply chains and construction, enhancing quality, cost-efficiency, and asset management.

Portfolio Pulse from

November 11, 2024 | 12:15 pm